Jeremy A. Anapol

Before joining Morgan Lewis, Jeremy was a partner at a national IP law firm.

• A global technology company in a New York patent case on natural language processing—obtained summary judgment of invalidity, securing complete victory for client
• A medical technology company as defendant in a Delaware jury trial involving three utility patents on smart watch technology—obtained jury verdict of noninfringement on all three
• A global electronics company as defendant in an East Texas patent case involving eight patents on microphone array technology—case settled after client filed counterclaims for breach of contract
• A medical technology company as plaintiff in a California bench trial involving trade secret, contract, and fiduciary duty claims—obtained permanent injunction against defendants’ competing product
• A global technology company in a West Texas patent case involving nine patents asserted against wireless earbuds and smart speakers—obtained transfer to Northern District of California (NDCA); filed IPR petitions against all nine patents; PTAB instituted the IPRs and NDCA granted stay; case settled
• A global technology company in an East Texas patent case on smart speakers—secured favorable claim construction and summary judgment eliminating most damages before trial; prevailed on noninfringement at the Federal Circuit
• A cybersecurity client in a California patent case involving 43 claims of three patents—drafted successful §101 motion to dismiss all claims and prevailed on appeal at the Federal Circuit; successfully opposed certiorari at US Supreme Court
• A defendant in multidistrict litigation (MDL) involving magnetic resonance imaging (MRI) systems—argued claim construction issues for all defendants in MDL and secured favorable rulings; elicited key admissions in deposition of inventor; case settled
• A publicly traded software company as petitioner in a Patent Office challenge that caused patentee to disclaim 15 challenged claims—case settled
• A multinational consumer products company in an IPR against competitor—drafted petition and briefs leading to 16 claims being held unpatentable; Federal Circuit affirmed in full; competitor subsequently acquired relevant division of client for $4.3 billion
• A medical technology company in the antitrust phase of a Delaware patent case against a multinational competitor—resolved through $300 million settlement payment to client
• A global technology company in a Delaware patent case on 58 claims of seven patents asserted against numerous products—drafted IPR petitions and dispositive motion that invalidated all claims; obtained full affirmance at the Federal Circuit
• A medical technology company in a breach of contract arbitration—cross-examined key witnesses and elicited admission that led to a multimillion-dollar award for client.